AstraZeneca (AZN) Share Price & Analysis 538Followers AZN Stock Chart & Stats Advanced Chart > 10,450.00p 8.00p(0.08%) At close:Dec 284:00 PM EST Created with Highcharts 11.3.0 30 …7 Oct14 Oct21 Oct28 Oct4 Nov11 Nov18 Nov25 Nov2 Dec9 Dec16 Dec23 Dec9,000p10,000p11,000p12,...
AstraZeneca Announces Share Capital and Voting Rights Update Jan. 2, 2025 at 10:02 a.m. ETon TipRanks.com Hutchmed announces NDA acceptance in China, payment from AstraZeneca Jan. 1, 2025 at 7:05 p.m. ETon TipRanks.com Levi & Korsinsky LLP Announces the Filing of a Securities Class ...
AstraZeneca PLC AZN:LSE Actions Health CarePharmaceuticals and Biotechnology Price (GBX)10,982.00 Today's Change-6.00 / -0.05% Shares traded3.04m 1 Year change+0.75% Beta0.3752 Data delayed at least 20 minutes, as of Jan 10 2025 14:42 GMT....
Latest AstraZeneca PLC (AZNA:VIE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
In a nutshell, Beta is a measure of individual stock risk relative to theoverall volatilityof the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict ho...
Date Type Shareholder Title Transaction Type Share Price Shares Value May 5, 2023 Sale Aradhana Sarin Disposition $74.81 PER SHARE 19,470 $1,456,551 Apr 28, 2023 Purchase Michel Demaré Acquisition $117.01 PER SHARE 2,000 $234,020 Mar 23, 2023 Purchase Pascal Soriot Derivative/Non-deriv...
Financial considerations Under the terms of the definitive agreement, AstraZeneca will acquire all of Gracell’s fully diluted share capital (including shares represented by ADSs) through a merger for a price of $2.00 per ordinary share in cash at closing (...
I am glad I spent a fair portion of my life in Europe to see all the historical monuments before these people feel the need to destroy the world over two provinces in Ukraine. I fear this time, the monuments will not survive. Pray for civilization for we have madmen leading the West ...
or enhancing to core operating margins should be interpreted to mean that earnings per share or core operating margins ofAstraZenecaorAlexionfor the current or future financial years would necessarily match or exceed the historical published earnings per share or core operating margins ofAstra...
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates.